By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Simulations Plus, Inc.

Simulations Plus, Inc. (SLP)

NASDAQ Currency in USD
$14.36
+$0.47
+3.38%
Last Update: 11 Sept 2025, 20:00
$289.03M
Market Cap
-4.56
P/E Ratio (TTM)
Forward Dividend Yield
$12.39 - $37.67
52 Week Range

SLP Stock Price Chart

Explore Simulations Plus, Inc. interactive price chart. Choose custom timeframes to analyze SLP price movements and trends.

SLP Company Profile

Discover essential business fundamentals and corporate details for Simulations Plus, Inc. (SLP) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Healthcare Information Services

IPO Date

18 Jun 1997

Employees

243.00

CEO

John Anthony DiBella

Description

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, a quantitative systems pharmacology software; NAFLDsym; IPFsym; RENAsym; and MITOsym. In addition, the company provides Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as modeling and simulation products comprising MonolixSuite and PKPlus. Further, it provides population modeling and simulation contract research services; training and consulting services designed to accelerate pharmacometrics studies; and clinical-pharmacology-based consulting services in support of regulatory submissions. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.

SLP Financial Timeline

Browse a chronological timeline of Simulations Plus, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 1 Apr 2026

Upcoming earnings on 5 Jan 2026

Upcoming earnings on 22 Oct 2025

EPS estimate is $0.07.

Earnings released on 14 Jul 2025

EPS came in at $0.45 surpassing the estimated $0.26 by +73.08%, while revenue for the quarter reached $20.36M , missing expectations by -2.69%.

Earnings released on 3 Apr 2025

EPS came in at $0.31 surpassing the estimated $0.25 by +24.00%, while revenue for the quarter reached $22.43M , beating expectations by +2.31%.

Earnings released on 7 Jan 2025

EPS came in at $0.17 falling short of the estimated $0.18 by -5.56%, while revenue for the quarter reached $18.92M , beating expectations by +0.63%.

Earnings released on 23 Oct 2024

EPS came in at $0.06 falling short of the estimated $0.07 by -9.09%, while revenue for the quarter reached $18.66M , missing expectations by -5.45%.

Earnings released on 2 Jul 2024

EPS came in at $0.15 matching the estimated $0.15, while revenue for the quarter reached $18.54M , missing expectations by -6.39%.

Dividend declared on 2 Jul 2024

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 5 Aug 2024.

Earnings released on 3 Apr 2024

EPS came in at $0.20 surpassing the estimated $0.19 by +5.26%, while revenue for the quarter reached $18.31M , beating expectations by +5.93%.

Dividend declared on 3 Apr 2024

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 6 May 2024.

Earnings released on 3 Jan 2024

EPS came in at $0.10 matching the estimated $0.10, while revenue for the quarter reached $14.50M , beating expectations by +4.17%.

Dividend declared on 3 Jan 2024

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 5 Feb 2024.

Earnings released on 25 Oct 2023

EPS came in at $0.18 matching the estimated $0.18, while revenue for the quarter reached $15.63M , missing expectations by -7.03%.

Dividend declared on 25 Oct 2023

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 6 Nov 2023.

Earnings released on 6 Jul 2023

EPS came in at $0.20 matching the estimated $0.20, while revenue for the quarter reached $16.23M , missing expectations by -3.43%.

Dividend declared on 6 Jul 2023

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 7 Aug 2023.

Earnings released on 5 Apr 2023

EPS came in at $0.20 surpassing the estimated $0.18 by +11.11%, while revenue for the quarter reached $15.75M , missing expectations by -2.36%.

Dividend declared on 5 Apr 2023

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 1 May 2023.

Earnings released on 4 Jan 2023

EPS came in at $0.06 falling short of the estimated $0.09 by -33.33%, while revenue for the quarter reached $11.96M , missing expectations by -3.20%.

Dividend declared on 4 Jan 2023

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 6 Feb 2023.

Earnings released on 26 Oct 2022

EPS came in at $0.07 falling short of the estimated $0.09 by -22.22%, while revenue for the quarter reached $11.73M , beating expectations by +7.40%.

Dividend declared on 20 Oct 2022

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 7 Nov 2022.

Earnings released on 6 Jul 2022

EPS came in at $0.20 surpassing the estimated $0.18 by +11.11%, while revenue for the quarter reached $14.96M , beating expectations by +4.30%.

Dividend declared on 6 Jul 2022

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 1 Aug 2022.

Earnings released on 6 Apr 2022

EPS came in at $0.21 surpassing the estimated $0.14 by +50.00%, while revenue for the quarter reached $14.80M , beating expectations by +2.09%.

Dividend declared on 6 Apr 2022

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 2 May 2022.

Earnings released on 6 Jan 2022

EPS came in at $0.15 surpassing the estimated $0.09 by +66.67%, while revenue for the quarter reached $12.42M , beating expectations by +21.21%.

Dividend declared on 6 Jan 2022

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 7 Feb 2022.

Earnings released on 25 Oct 2021

EPS came in at $0.01 falling short of the estimated $0.08 by -87.50%, while revenue for the quarter reached $9.84M , beating expectations by +20.45%.

Dividend declared on 13 Oct 2021

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 1 Nov 2021.

Earnings released on 12 Jul 2021

EPS came in at $0.18 matching the estimated $0.18, while revenue for the quarter reached $12.78M , missing expectations by -13.32%.

Dividend declared on 12 Jul 2021

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 2 Aug 2021.

Earnings released on 12 Apr 2021

EPS came in at $0.15 surpassing the estimated $0.14 by +7.14%, while revenue for the quarter reached $13.15M , beating expectations by +7.69%.

Dividend declared on 12 Apr 2021

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 3 May 2021.

Earnings released on 11 Jan 2021

EPS came in at $0.12 surpassing the estimated $0.11 by +9.09%, while revenue for the quarter reached $10.70M , beating expectations by +10.00%.

Dividend declared on 11 Jan 2021

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 1 Feb 2021.

Earnings released on 16 Nov 2020

EPS came in at $0.11 surpassing the estimated $0.09 by +22.22%, while revenue for the quarter reached $9.54M .

Dividend declared on 13 Oct 2020

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 2 Nov 2020.

SLP Stock Performance

Access detailed SLP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run